These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 35350013
1. Twenty Years of Neonatal Screening for Congenital Adrenal Hyperplasia in North-Eastern Italy: Role of Liquid Chromatography-Tandem Mass Spectrometry as a Second-Tier Test. Cavarzere P, Camilot M, Palma L, Lauriola S, Gaudino R, Vincenzi M, Antoniazzi F, Teofoli F, Piacentini G. Horm Res Paediatr; 2022; 95(3):255-263. PubMed ID: 35350013 [Abstract] [Full Text] [Related]
2. Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China. Zhan X, Han L, Qiu W, Gu X, Guo J, Chang S, Wang Y, Zhang H. Steroids; 2022 Sep; 185():109056. PubMed ID: 35660382 [Abstract] [Full Text] [Related]
3. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation. Seo JY, Park HD, Kim JW, Oh HJ, Yang JS, Chang YS, Park WS, Lee SY. J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111 [Abstract] [Full Text] [Related]
4. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants. Güran T, Tezel B, Çakır M, Akıncı A, Orbak Z, Keskin M, Selver Eklioğlu B, Ozon A, Özbek MN, Karagüzel G, Hatipoğlu N, Gürbüz F, Çizmecioğlu FM, Kara C, Şimşek E, Baş F, Aydın M, Darendeliler F. J Clin Res Pediatr Endocrinol; 2020 Sep 02; 12(3):287-294. PubMed ID: 32157855 [Abstract] [Full Text] [Related]
5. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants. Güran T, Tezel B, Gürbüz F, Selver Eklioğlu B, Hatipoğlu N, Kara C, Şimşek E, Çizmecioğlu FM, Ozon A, Baş F, Aydın M, Darendeliler F. J Clin Res Pediatr Endocrinol; 2019 Feb 20; 11(1):13-23. PubMed ID: 30111524 [Abstract] [Full Text] [Related]
6. Development and evaluation of a candidate reference measurement procedure for detecting 17α-hydroxyprogesterone in dried blood spots using isotope dilution liquid chromatography tandem mass spectrometry. He Z, Dai H, Shen J, Huang Y, Liu J, Yan R, Zhang F, Yan S. Anal Bioanal Chem; 2024 Aug 20; 416(20):4635-4645. PubMed ID: 38949681 [Abstract] [Full Text] [Related]
7. A case of 11beta-hydroxylase deficiency detected in a newborn screening program by second-tier LC-MS/MS. Peter M, Janzen N, Sander S, Korsch E, Riepe FG, Sander J. Horm Res; 2008 Aug 20; 69(4):253-6. PubMed ID: 18204274 [Abstract] [Full Text] [Related]
8. Second-tier Testing for 21-Hydroxylase Deficiency in the Netherlands: A Newborn Screening Pilot Study. Stroek K, Ruiter A, van der Linde A, Ackermans M, Bouva MJ, Engel H, Jakobs B, Kemper EA, van den Akker ELT, van Albada ME, Bocca G, Finken MJJ, Hannema SE, Mieke Houdijk ECA, van der Kamp HJ, van Tellingen V, Paul van Trotsenburg AS, Zwaveling-Soonawala N, Bosch AM, de Jonge R, Heijboer AC, Claahsen-van der Grinten HL, Boelen A. J Clin Endocrinol Metab; 2021 Oct 21; 106(11):e4487-e4496. PubMed ID: 34171085 [Abstract] [Full Text] [Related]
10. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J. J Clin Endocrinol Metab; 2007 Jul 21; 92(7):2581-9. PubMed ID: 17456574 [Abstract] [Full Text] [Related]
11. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing. Janzen N, Riepe FG, Peter M, Sander S, Steuerwald U, Korsch E, Krull F, Müller HL, Heger S, Brack C, Sander J. Horm Res Paediatr; 2012 Jul 21; 77(3):195-9. PubMed ID: 22508345 [Abstract] [Full Text] [Related]
16. Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening. Monostori P, Szabó P, Marginean O, Bereczki C, Karg E. Horm Res Paediatr; 2015 Jun 21; 84(5):311-8. PubMed ID: 26397944 [Abstract] [Full Text] [Related]
18. Determination of a steroid profile in heel prick blood using LC-MS/MS. Boelen A, Ruiter AF, Claahsen-van der Grinten HL, Endert E, Ackermans MT. Bioanalysis; 2016 Jun 21; 8(5):375-84. PubMed ID: 26891684 [Abstract] [Full Text] [Related]
19. Rapid screening assay of congenital adrenal hyperplasia by measuring 17 alpha-hydroxyprogesterone with high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots. Lai CC, Tsai CH, Tsai FJ, Wu JY, Lin WD, Lee CC. J Clin Lab Anal; 2002 Jun 21; 16(1):20-5. PubMed ID: 11835526 [Abstract] [Full Text] [Related]
20. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Lacey JM, Minutti CZ, Magera MJ, Tauscher AL, Casetta B, McCann M, Lymp J, Hahn SH, Rinaldo P, Matern D. Clin Chem; 2004 Mar 21; 50(3):621-5. PubMed ID: 14656905 [Abstract] [Full Text] [Related] Page: [Next] [New Search]